Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Cardiovascular Abnormalities Clinical Trials

A listing of Cardiovascular Abnormalities medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

This study is looking at investigational drug, SAR236553, in patients who experienced a coronary event. One of the main risk factors for developing coronary heart disease is high levels of cholesterol in the blood, in particular high levels of a particular type of cholesterol called LDL-cholesterol (bad cholesterol). SAR236553 is ...

Phase

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

A 8 to 12 Week Randomized, Double-Blind Study to Compare the Fixed-Dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10mg Monotherapy as First Line Therapy in Type 2 Diebetes Patients with Hypertension (High Blood Pressure) Patient Inclusion Criteria: Men or Women 18 Years of Age or Older May ...

Phase

Researchers at the University of Kentucky are conducting a clinical research study of lipoproteins (the carriers of both "good" and "bad" cholesterol in the blood). The purpose of this study is to determine the changes in lipoproteins that occur with weight loss. We will also research various markers of inflammation ...

Phase N/A

What is the purpose of this study? This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of aortic growth and other cardiovascular outcomes. What is involved? This study lasts for three years and includes six visits. ...

Phase N/A

The primary endpoint of this study is the time to first  occurrence of any component of the composite endpoint, as adjudicated by the Clinical  Endpoint Committee (CEC). Components of the primary endpoint are:               Cardiovascular (CV) death      Resuscitated cardiac arrest    Non-­fatal MI         Non-­fatal stroke 

Phase

Researchers at the University of Kentucky Gill Heart Institute are inviting you to learn more about a clinical study for blood pressure that is not adequately controlled with medications. Researchers are investigating a device to lower blood pressure that is beyond lifestyle and medication changes. This clinical study involves approximately ...

Phase N/A

Researchers at the University of Kentucky Gill Heart & Vascular Institute are inviting you to participate in a clinical research study evaluating an investigational implantable device designed to send electrical signals to balance the cardiovascular system. To learn more, visit: www.HeartFailureStudy.com

Phase N/A

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

150 patients will be prospectively consented/screened. Over the course of the study, 30 patients are expected to develop abnormal strain with a normal EF > 53%. They will be randomized in 1:1 fashion to open label carvedilol vs. no treatment. All consenting patients will receive a baseline echocardiogram and blood ...

Phase

Transcutaneous Electrical Nerve Stimulation and Cardiac Sympathetic Overdrive in Heart Failure

Introduction: Cardiac sympathetic drive provides inotropic support to the failing heart and preserves cardiovascular homeostasis. Nonetheless, as myocardial insult evolves, this compensatory response leads to a progressive decline in contractile function, increases the vulnerability to arrhythmias and constitutes an independent mortality predictor. Despite advanced pharmacological therapies, side effects and persistent ...

Phase N/A